TreeWAS – Variant ID: rs7729356

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N60.4 Mammary duct ectasia	0.000	0.829	0.171
N60 Benign mammary dysplasia	0.000	0.829	0.171
N60.1 Diffuse cystic mastopathy	0.000	0.838	0.162
N60.8 Other benign mammary dysplasias	0.000	0.840	0.160
N60.3 Fibrosclerosis of breast	0.000	0.847	0.153
N60.2 Fibroadenosis of breast	0.000	0.864	0.136
N60.0 Solitary cyst of breast	0.000	0.877	0.123
N60.9 Benign mammary dysplasia, unspecified	0.000	0.891	0.108
L57.0 Actinic keratosis	0.000	0.976	0.024
T36-T50 Poisoning by drugs, medicaments and biological substances	0.021	0.979	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.020	0.980	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.020	0.980	0.000
T40.4 Other synthetic narcotics	0.020	0.980	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.020	0.980	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.000	0.981	0.019
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.019	0.981	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.019	0.981	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.018	0.982	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.018	0.982	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.017	0.983	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.017	0.983	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.017	0.983	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.017	0.983	0.000
T40.6 Other and unspecified narcotics	0.017	0.983	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.017	0.983	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.016	0.984	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.016	0.984	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.000	0.984	0.016
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.016	0.984	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.016	0.984	0.000
T36 Poisoning by systemic antibiotics	0.016	0.984	0.000
T40.3 Methadone	0.016	0.984	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.000	0.984	0.016
T41 Poisoning by anaesthetics and therapeutic gases	0.015	0.984	0.000
T43.9 Psychotropic drug, unspecified	0.015	0.985	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.015	0.985	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.015	0.985	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.015	0.985	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.015	0.985	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.015	0.985	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.015	0.985	0.000
T43.6 Psychostimulants with abuse potential	0.015	0.985	0.000
T47.0 Histamine H(2)-receptor antagonists	0.015	0.985	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.014	0.985	0.000
T40.8 Lysergide [LSD]	0.014	0.985	0.000
T40.7 Cannabis (derivatives)	0.014	0.985	0.000
T40.1 Heroin	0.014	0.985	0.000
T40.0 Opium	0.014	0.985	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.014	0.985	0.000
T47.4 Other laxatives	0.014	0.986	0.000
T38.0 Glucocorticoids and synthetic analogues	0.014	0.986	0.000
T48.5 Anti-common-cold drugs	0.014	0.986	0.000
T38.5 Other oestrogens and progestogens	0.014	0.986	0.000
T45.4 Iron and its compounds	0.014	0.986	0.000
L57.3 Poikiloderma of Civatte	0.000	0.986	0.014
L57.2 Cutis rhomboidalis nuchae	0.000	0.986	0.014
L57.1 Actinic reticuloid	0.000	0.986	0.014
T46.4 Angiotensin-converting-enzyme inhibitors	0.014	0.986	0.000
T40.5 Cocaine	0.014	0.986	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.014	0.986	0.000
T37.5 Antiviral drugs	0.014	0.986	0.000
T37.4 Anthelminthics	0.014	0.986	0.000
T37.3 Other antiprotozoal drugs	0.014	0.986	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.014	0.986	0.000
T37.1 Antimycobacterial drugs	0.014	0.986	0.000
T37.0 Sulphonamides	0.014	0.986	0.000
T42.0 Hydantoin derivatives	0.014	0.986	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.014	0.986	0.000
T42.3 Barbiturates	0.014	0.986	0.000
T42.2 Succinimides and oxazolidinediones	0.014	0.986	0.000
T42.4 Benzodiazepines	0.014	0.986	0.000
L57.4 Cutis laxa senilis	0.000	0.986	0.013
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.013	0.987	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.013	0.987	0.000
T47.7 Emetics	0.013	0.987	0.000
T47.6 Antidiarrhoeal drugs	0.013	0.987	0.000
T47.5 Digestants	0.013	0.987	0.000
T47.3 Saline and osmotic laxatives	0.013	0.987	0.000
T47.2 Stimulant laxatives	0.013	0.987	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.013	0.987	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.013	0.987	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.013	0.987	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.013	0.987	0.000
L57.5 Actinic granuloma	0.000	0.987	0.013
T38.9 Other and unspecified hormone antagonists	0.013	0.987	0.000
T38.7 Androgens and anabolic congeners	0.013	0.987	0.000
T38.4 Oral contraceptives	0.013	0.987	0.000
T38.2 Antithyroid drugs	0.013	0.987	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.000	0.987	0.013
T38.1 Thyroid hormones and substitutes	0.013	0.987	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.012	0.987	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.012	0.987	0.000
T46.7 Peripheral vasodilators	0.012	0.987	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.012	0.987	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.012	0.987	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.012	0.987	0.000
T48.4 Expectorants	0.012	0.987	0.000
T48.3 Antitussives	0.012	0.987	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.012	0.987	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.012	0.987	0.000
T48.0 Oxytocic drugs	0.012	0.987	0.000
T45.5 Anticoagulants	0.012	0.988	0.000
T46.1 Calcium-channel blockers	0.012	0.988	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.012	0.988	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.012	0.988	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.012	0.988	0.000
T45.8 Other primarily systemic and haematological agents	0.012	0.988	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.012	0.988	0.000
T45.6 Fibrinolysis-affecting drugs	0.012	0.988	0.000
T45.3 Enzymes, not elsewhere classified	0.012	0.988	0.000
L56 Other acute skin changes due to ultraviolet radiation	0.000	0.988	0.012
T36.0 Penicillins	0.012	0.988	0.000
T49.9 Topical agent, unspecified	0.012	0.988	0.000
T49.8 Other topical agents	0.012	0.988	0.000
T49.7 Dental drugs, topically applied	0.012	0.988	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.012	0.988	0.000
T49.5 Ophthalmological drugs and preparations	0.012	0.988	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.988	0.000
T49.3 Emollients, demulcents and protectants	0.012	0.988	0.000
T49.2 Local astringents and local detergents	0.012	0.988	0.000
T49.1 Antipruritics	0.012	0.988	0.000
T36.9 Systemic antibiotic, unspecified	0.011	0.988	0.000
T36.8 Other systemic antibiotics	0.011	0.988	0.000
T36.7 Antifungal antibiotics, systemically used	0.011	0.988	0.000
T36.6 Rifamycins	0.011	0.988	0.000
T36.5 Aminoglycosides	0.011	0.988	0.000
T36.4 Tetracyclines	0.011	0.988	0.000
T36.3 Macrolides	0.011	0.988	0.000
T36.2 Chloramphenicol group	0.011	0.988	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.011	0.988	0.000
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.000	0.989	0.011
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.011	0.989	0.000
T41.5 Therapeutic gases	0.011	0.989	0.000
T41.4 Anaesthetic, unspecified	0.011	0.989	0.000
T41.3 Local anaesthetics	0.011	0.989	0.000
T41.2 Other and unspecified general anaesthetics	0.011	0.989	0.000
T41.1 Intravenous anaesthetics	0.011	0.989	0.000
T41.0 Inhaled anaesthetics	0.011	0.989	0.000
T45.0 Antiallergic and antiemetic drugs	0.011	0.989	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.011	0.989	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.011	0.989	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.989	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.011	0.989	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.989	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.989	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.989	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.989	0.000
T44.0 Anticholinesterase agents	0.011	0.989	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.010	0.990	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.010	0.990	0.000
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
T45.2 Vitamins, not elsewhere classified	0.010	0.990	0.000
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.000	0.990	0.010
M20.4 Other hammer toe(s) (acquired)	0.000	0.990	0.010
T39.0 Salicylates	0.010	0.990	0.000
T50.7 Analeptics and opioid receptor antagonists	0.010	0.990	0.000
T50.5 Appetite depressants	0.010	0.990	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.010	0.990	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.010	0.990	0.000
T50.1 Loop [high-ceiling] diuretics	0.010	0.990	0.000
T50.0 Mineralocorticoids and their antagonists	0.010	0.990	0.000
R26.8 Other and unspecified abnormalities of gait and mobility	0.010	0.990	0.000
T42.1 Iminostilbenes	0.009	0.990	0.000
L58 Radiodermatitis	0.000	0.991	0.009
L55 Sunburn	0.000	0.991	0.009
R07.1 Chest pain on breathing	0.009	0.991	0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.000	0.991	0.009
N75.1 Abscess of Bartholin's gland	0.000	0.991	0.009
Z93.1 Gastrostomy status	0.009	0.991	0.000
L56.3 Solar urticaria	0.000	0.991	0.009
L56.2 Photocontact dermatitis [berloque dermatitis]	0.000	0.991	0.009
L56.1 Drug photoallergic response	0.000	0.991	0.009
L56.0 Drug phototoxic response	0.000	0.991	0.009
T50.8 Diagnostic agents	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.008	0.992	0.000
L56.4 Polymorphous light eruption	0.000	0.992	0.008
T39.4 Antirheumatics, not elsewhere classified	0.008	0.992	0.000
T39.2 Pyrazolone derivatives	0.008	0.992	0.000
Y86 Sequelae of other accidents	0.008	0.992	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.008	0.992	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992	0.000
R26 Abnormalities of gait and mobility	0.008	0.992	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
L55.9 Sunburn, unspecified	0.000	0.993	0.007
L55.8 Other sunburn	0.000	0.993	0.007
L55.2 Sunburn of third degree	0.000	0.993	0.007
L55.1 Sunburn of second degree	0.000	0.993	0.007
L55.0 Sunburn of first degree	0.000	0.993	0.007
L58.9 Radiodermatitis, unspecified	0.000	0.993	0.007
L58.1 Chronic radiodermatitis	0.000	0.993	0.007
L58.0 Acute radiodermatitis	0.000	0.993	0.007
L59.0 Erythema ab igne [dermatitis ab igne]	0.000	0.993	0.007
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.000	0.993	0.007
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.000	0.993	0.007
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.007	0.993	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
R26.0 Ataxic gait	0.007	0.993	0.000
R26.3 Immobility	0.006	0.994	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.006	0.994	0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.006	0.994	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.006	0.994	0.000
T40.2 Other opioids	0.006	0.994	0.000
Z85.6 Personal history of leukaemia	0.006	0.994	0.000
Y87.1 Sequelae of assault	0.006	0.994	0.000
N85.2 Hypertrophy of uterus	0.000	0.994	0.006
R26.1 Paralytic gait	0.006	0.994	0.000
Y87.0 Sequelae of intentional self-harm	0.005	0.995	0.000
Y88 Sequelae of surgical and medical care as external cause	0.005	0.995	0.000
Y87.2 Sequelae of events of undetermined intent	0.005	0.995	0.000
Y88.1 Sequelae of misadventures to patients during surgical and medical procedures	0.005	0.995	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.005	0.995	0.000
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)	0.005	0.995	0.000
R26.2 Difficulty in walking, not elsewhere classified	0.005	0.995	0.000
Y85 Sequelae of transport accidents	0.005	0.995	0.000
M75.5 Bursitis of shoulder	0.000	0.995	0.005
Y85.9 Sequelae of other and unspecified transport accidents	0.005	0.995	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.004	0.996	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.004	0.996	0.000
Y88.2 Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use	0.004	0.996	0.000
Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
Y89 Sequelae of other external causes	0.004	0.996	0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.004	0.996	0.000
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.004	0.996	0.000
E83.4 Disorders of magnesium metabolism	0.004	0.996	0.000
R25 Abnormal involuntary movements	0.004	0.996	0.000
A63.0 Anogenital (venereal) warts	0.000	0.996	0.003
R25.8 Other and unspecified abnormal involuntary movements	0.003	0.997	0.000
D68 Other coagulation defects	0.003	0.997	0.000
R25.1 Tremor, unspecified	0.003	0.997	0.000
F22.0 Delusional disorder	0.003	0.997	0.000
D68.5 Primary Thrombophilia	0.003	0.997	0.000
R25.3 Fasciculation	0.003	0.997	0.000
S82.00 Fracture of patella (closed)	0.000	0.997	0.003
I49.4 Other and unspecified premature depolarisation	0.003	0.997	0.000
Y89.1 Sequelae of war operations	0.003	0.997	0.000
Y89.0 Sequelae of legal intervention	0.003	0.997	0.000
M22.2 Patellofemoral disorders	0.003	0.997	0.000
O03.4 Incomplete, without complication	0.003	0.997	0.000
N75 Diseases of Bartholin's gland	0.000	0.997	0.003
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
D68.8 Other specified coagulation defects	0.003	0.997	0.000
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.003	0.997	0.000
J95.8 Other postprocedural respiratory disorders	0.003	0.997	0.000
I31.3 Pericardial effusion (noninflammatory)	0.000	0.997	0.003
N81.1 Cystocele	0.000	0.997	0.003
R25.0 Abnormal head movements	0.003	0.997	0.000
B07 Viral warts	0.000	0.997	0.003
D68.6 Other Thrombophilia	0.003	0.997	0.000
D68.4 Acquired coagulation factor deficiency	0.003	0.997	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.003	0.997	0.000
B00.5 Herpesviral ocular disease	0.000	0.997	0.003
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.997	0.003
B08.1 Molluscum contagiosum	0.000	0.997	0.003
Z93 Artificial opening status	0.003	0.997	0.000
D68.1 Hereditary factor XI deficiency	0.003	0.997	0.000
Z93.8 Other artificial opening status	0.003	0.997	0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.000	0.997	0.003
G72.9 Myopathy, unspecified	0.003	0.997	0.000
Z93.9 Artificial opening status, unspecified	0.003	0.997	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.003	0.997	0.000
Q24.8 Other specified congenital malformations of heart	0.003	0.997	0.000
I62 Other nontraumatic intracranial haemorrhage	0.003	0.997	0.000
D69.6 Thrombocytopenia, unspecified	0.003	0.997	0.000
Q24.5 Malformation of coronary vessels	0.003	0.997	0.000
D68.0 Von Willebrand's disease	0.003	0.997	0.000
S82.01 Fracture of patella (open)	0.000	0.997	0.003
R29.2 Abnormal reflex	0.002	0.997	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.997	0.003
Q24 Other congenital malformations of heart	0.003	0.997	0.000
D68.2 Hereditary deficiency of other clotting factors	0.003	0.997	0.000
I12.0 Hypertensive renal disease with renal failure	0.000	0.998	0.002
N75.9 Disease of Bartholin's gland, unspecified	0.000	0.998	0.002
N75.8 Other diseases of Bartholin's gland	0.000	0.998	0.002
Q24.9 Congenital malformation of the heart, unspecified	0.002	0.998	0.000
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.002	0.998	0.000
M86.99 Osteomyelitis, unspecified (Site unspecified)	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
D72.8 Other specified disorders of white blood cells	0.000	0.998	0.002
E27.2 Addisonian crisis	0.002	0.998	0.000
E27.1 Primary adrenocortical insufficiency	0.002	0.998	0.000
R29.4 Clicking hip	0.002	0.998	0.000
R29.3 Abnormal posture	0.002	0.998	0.000
R29.0 Tetany	0.002	0.998	0.000
Y89.9 Sequelae of unspecified external cause	0.002	0.998	0.000
E27 Other disorders of adrenal gland	0.002	0.998	0.000
Z93.6 Other artificial openings of urinary tract status	0.002	0.998	0.000
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.000	0.998	0.002
B00 Herpesviral [herpes simplex] infections	0.000	0.998	0.002
Q24.0 Dextrocardia	0.002	0.998	0.000
S10.9 Superficial injury of neck, part unspecified	0.002	0.998	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.002	0.998	0.000
Z63.4 Disappearance and death of family member	0.002	0.998	0.000
S82.0 Fracture of patella	0.000	0.998	0.002
D69 Purpura and other haemorrhagic conditions	0.002	0.998	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.002	0.998	0.000
I49.5 Sick sinus syndrome	0.002	0.998	0.000
L23.5 Allergic contact dermatitis due to other chemical products	0.002	0.998	0.000
R52.9 Pain, unspecified	0.000	0.998	0.002
R29.1 Meningismus	0.002	0.998	0.000
M24.27 Disorder of ligament (Ankle and foot)	0.000	0.998	0.002
J86.0 Pyothorax with fistula	0.002	0.998	0.000
J95.5 Postprocedural subglottic stenosis	0.002	0.998	0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.002	0.998	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.002	0.998	0.000
S02.8 Fractures of other skull and facial bones	0.002	0.998	0.000
Y04.2 School, other institution and public administrative area	0.002	0.998	0.000
Z93.3 Colostomy status	0.002	0.998	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.002	0.998	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.998	0.002
M79.4 Hypertrophy of (infrapatellar) fat pad	0.002	0.998	0.000
R29.6 Tendency to fall, not elsewhere classified	0.002	0.998	0.000
Q24.6 Congenital heart block	0.002	0.998	0.000
Q24.4 Congenital subaortic stenosis	0.002	0.998	0.000
Q24.3 Pulmonary infundibular stenosis	0.002	0.998	0.000
Q24.2 Cor triatriatum	0.002	0.998	0.000
Q24.1 Levocardia	0.002	0.998	0.000
D69.5 Secondary thrombocytopenia	0.002	0.998	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.002	0.998	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.002	0.998	0.000
G71.3 Mitochondrial myopathy, not elsewhere classified	0.002	0.998	0.000
Z93.0 Tracheostomy status	0.002	0.998	0.000
I62.1 Nontraumatic extradural haemorrhage	0.002	0.998	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.000	0.998	0.002
C45.0 Mesothelioma of pleura	0.002	0.998	0.000
H60.5 Acute otitis externa, non-infective	0.002	0.998	0.000
I99 Other and unspecified disorders of circulatory system	0.000	0.998	0.002
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.000	0.998	0.002
J84 Other interstitial pulmonary diseases	0.000	0.998	0.002
J95.0 Tracheostomy malfunction	0.002	0.998	0.000
B00.8 Other forms of herpesviral infection	0.000	0.998	0.002
B00.7 Disseminated herpesviral disease	0.000	0.998	0.002
B00.3 Herpesviral meningitis	0.000	0.998	0.002
B00.0 Eczema herpeticum	0.000	0.998	0.002
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.000	0.998	0.002
B08.5 Enteroviral vesicular pharyngitis	0.000	0.998	0.002
B08.4 Enteroviral vesicular stomatitis with exanthem	0.000	0.998	0.002
B08.3 Erythema infectiosum [fifth disease]	0.000	0.998	0.002
B08.2 Exanthema subitum [sixth disease]	0.000	0.998	0.002
B08.0 Other orthopoxvirus infections	0.000	0.998	0.002
D69.9 Haemorrhagic condition, unspecified	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.002	0.998	0.000
E27.0 Other adrenocortical overactivity	0.002	0.998	0.000
D69.4 Other primary thrombocytopenia	0.002	0.998	0.000
D69.2 Other nonthrombocytopenic purpura	0.002	0.998	0.000
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.000	0.998	0.002
H60.3 Other infective otitis externa	0.002	0.998	0.000
M86.87 Other osteomyelitis (Ankle and foot)	0.002	0.998	0.000
J95.4 Mendelson's syndrome	0.002	0.998	0.000
J95.3 Chronic pulmonary insufficiency following surgery	0.002	0.998	0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.002	0.998	0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.002	0.998	0.000
B00.9 Herpesviral infection, unspecified	0.000	0.998	0.002
D69.8 Other specified haemorrhagic conditions	0.002	0.998	0.000
D69.1 Qualitative platelet defects	0.002	0.998	0.000
M86.9 Osteomyelitis, unspecified	0.002	0.998	0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.000	0.998	0.002
C92.0 Acute myeloid leukaemia	0.002	0.998	0.000
I49.9 Cardiac arrhythmia, unspecified	0.002	0.998	0.000
D67 Hereditary factor IX deficiency	0.002	0.998	0.000
F22 Persistent delusional disorders	0.002	0.998	0.000
R27 Other lack of coordination	0.002	0.998	0.000
B00.4 Herpesviral encephalitis	0.000	0.998	0.002
B00.1 Herpesviral vesicular dermatitis	0.000	0.998	0.002
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.998	0.002
M86.8 Other osteomyelitis	0.002	0.998	0.000
H60.1 Cellulitis of external ear	0.002	0.998	0.000
Y04.8 Other specified place	0.002	0.998	0.000
G71 Primary disorders of muscles	0.002	0.998	0.000
L23.1 Allergic contact dermatitis due to adhesives	0.002	0.998	0.000
M86.86 Other osteomyelitis (Lower leg)	0.002	0.998	0.000
S22.20 Fracture of sternum (closed)	0.002	0.998	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.998	0.002
S02.81 Fractures of other skull and facial bones (open)	0.002	0.998	0.000
G71.1 Myotonic disorders	0.002	0.998	0.000
Y85.0 Sequelae of motor-vehicle accident	0.002	0.998	0.000
C92 Myeloid leukaemia	0.002	0.998	0.000
F22.9 Persistent delusional disorder, unspecified	0.002	0.998	0.000
N75.0 Cyst of Bartholin's gland	0.000	0.998	0.002
G72 Other myopathies	0.002	0.998	0.000
M79.49 Hypertrophy of (infrapatellar) fat pad-Site unspec	0.002	0.998	0.000
M79.48 Hypertrophy of (infrapatellar) fat pad (Other)	0.002	0.998	0.000
M79.47 Hypertrophy of (infrapatellar) fat pad (Ankle and foot)	0.002	0.998	0.000
M79.45 Hypertrophy of (infrapatellar) fat pad (Pelvic region and thigh)	0.002	0.998	0.000
M79.44 Hypertrophy of (infrapatellar) fat pad (Hand)	0.002	0.998	0.000
M79.43 Hypertrophy of (infrapatellar) fat pad (Forearm)	0.002	0.998	0.000
M79.42 Hypertrophy of (infrapatellar) fat pad (Upper arm)	0.002	0.998	0.000
M79.41 Hypertrophy of (infrapatellar) fat pad (Shoulder region)	0.002	0.998	0.000
M79.40 Hypertrophy of (infrapatellar) fat pad (Multiple sites)	0.002	0.998	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.002	0.998	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.002	0.998	0.000
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.000	0.998	0.002
M22.8 Other disorders of patella	0.002	0.998	0.000
O70.0 First degree perineal laceration during delivery	0.000	0.998	0.002
H60 Otitis externa	0.002	0.998	0.000
M86.95 Osteomyelitis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
G71.0 Muscular dystrophy	0.002	0.998	0.000
D30.0 Kidney	0.000	0.998	0.002
J84.8 Other specified interstitial pulmonary diseases	0.000	0.998	0.002
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.002	0.998	0.000
Q25.1 Coarctation of aorta	0.002	0.998	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.000	0.998	0.002
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.000	0.998	0.002
B06 Rubella [German measles]	0.000	0.998	0.002
B05 Measles	0.000	0.998	0.002
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.000	0.998	0.002
B04 Monkeypox	0.000	0.998	0.002
B03 Smallpox	0.000	0.998	0.002
L23 Allergic contact dermatitis	0.002	0.998	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.998	0.002
J84.0 Alveolar and parietoalveolar conditions	0.000	0.998	0.002
M86.17 Other acute osteomyelitis (Ankle and foot)	0.002	0.998	0.000
L23.8 Allergic contact dermatitis due to other agents	0.002	0.998	0.000
Y04 Assault by bodily force	0.002	0.998	0.000
H60.4 Cholesteatoma of external ear	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
F60.9 Personality disorder, unspecified	0.002	0.998	0.000
H43.8 Other disorders of vitreous body	0.000	0.998	0.002
M86.1 Other acute osteomyelitis	0.002	0.998	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.001	0.998	0.000
M86.92 Osteomyelitis, unspecified (Upper arm)	0.001	0.998	0.000
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.001	0.998	0.000
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.001	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
I49 Other cardiac arrhythmias	0.002	0.998	0.000
M86 Osteomyelitis	0.002	0.998	0.000
M86.89 Other osteomyelitis (Site unspecified)	0.001	0.998	0.000
M86.88 Other osteomyelitis (Other)	0.001	0.998	0.000
M86.85 Other osteomyelitis (Pelvic region and thigh)	0.001	0.998	0.000
M86.84 Other osteomyelitis (Hand)	0.001	0.998	0.000
M86.83 Other osteomyelitis (Forearm)	0.001	0.998	0.000
M86.82 Other osteomyelitis (Upper arm)	0.001	0.998	0.000
M86.81 Other osteomyelitis (Shoulder region)	0.001	0.998	0.000
M86.80 Other osteomyelitis (Multiple sites)	0.001	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
F22.8 Other persistent delusional disorders	0.001	0.998	0.000
L02 Cutaneous abscess, furuncle and carbuncle	0.002	0.998	0.000
M86.65 Other chronic osteomyelitis (Pelvic region and thigh)	0.001	0.998	0.000
G71.9 Primary disorder of muscle, unspecified	0.001	0.998	0.000
G71.8 Other primary disorders of muscles	0.001	0.998	0.000
G71.2 Congenital myopathies	0.001	0.998	0.000
L23.3 Allergic contact dermatitis due to drugs in contact with the skin	0.002	0.998	0.000
Z35.0 Supervision of pregnancy with history of infertility	0.002	0.998	0.000
D66 Hereditary factor VIII deficiency	0.002	0.998	0.000
G72.0 Drug-induced myopathy	0.001	0.998	0.000
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.000	0.998	0.001
F60 Specific personality disorders	0.002	0.998	0.000
M86.94 Osteomyelitis, unspecified (Hand)	0.001	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.001	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.001	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.001	0.998	0.000
C92.3 Myeloid sarcoma	0.001	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.001	0.998	0.000
E87.3 Alkalosis	0.000	0.998	0.002
G72.3 Periodic paralysis	0.001	0.998	0.000
G72.2 Myopathy due to other toxic agents	0.001	0.998	0.000
G72.1 Alcoholic myopathy	0.001	0.998	0.000
H60.2 Malignant otitis externa	0.001	0.998	0.000
Z93.4 Other artificial openings of gastro-intestinal tract status	0.001	0.998	0.000
J86 Pyothorax	0.002	0.998	0.000
F60.5 Anankastic personality disorder	0.001	0.998	0.000
G72.8 Other specified myopathies	0.001	0.998	0.000
H60.8 Other otitis externa	0.001	0.998	0.000
H60.0 Abscess of external ear	0.001	0.998	0.000
J01.9 Acute sinusitis, unspecified	0.002	0.998	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.002	0.998	0.000
F60.0 Paranoid personality disorder	0.001	0.998	0.000
K72.0 Acute and subacute hepatic failure	0.002	0.998	0.000
Z35.1 Supervision of pregnancy with history of abortive outcome	0.002	0.998	0.000
B05.9 Measles without complication	0.000	0.998	0.001
B05.8 Measles with other complications	0.000	0.998	0.001
B05.4 Measles with intestinal complications	0.000	0.998	0.001
B05.3 Measles complicated by otitis media	0.000	0.998	0.001
B05.2 Measles complicated by pneumonia	0.000	0.998	0.001
B05.1 Measles complicated by meningitis	0.000	0.998	0.001
B05.0 Measles complicated by encephalitis	0.000	0.998	0.001
B06.9 Rubella without complication	0.000	0.998	0.001
B06.8 Rubella with other complications	0.000	0.998	0.001
B06.0 Rubella with neurological complications	0.000	0.998	0.001
F60.8 Other specific personality disorders	0.001	0.998	0.000
M86.6 Other chronic osteomyelitis	0.001	0.998	0.000
R59.1 Generalised enlarged lymph nodes	0.002	0.998	0.000
M89.55 Osteolysis (Pelvic region and thigh)	0.000	0.998	0.001
L23.7 Allergic contact dermatitis due to plants, except food	0.001	0.998	0.000
L23.6 Allergic contact dermatitis due to food in contact with the skin	0.001	0.998	0.000
L23.4 Allergic contact dermatitis due to dyes	0.001	0.998	0.000
L23.2 Allergic contact dermatitis due to cosmetics	0.001	0.998	0.000
L23.0 Allergic contact dermatitis due to metals	0.001	0.998	0.000
T59.8 Other specified gases, fumes and vapours	0.001	0.998	0.000
Z51.3 Blood transfusion without reported diagnosis	0.002	0.998	0.000
Z73.3 Stress, not elsewhere classified	0.002	0.998	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.001	0.998	0.000
M31.6 Other giant cell arteritis	0.002	0.998	0.000
Y04.9 Unspecified place	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations